Role of gelsolin in cell proliferation and invasion of human hepatocellular carcinoma cells

Gene

Volumn 571, Issue 2, 2015, Pages 292-297

  Deng, Biao ^a   Fang, JiaQing ^b   Zhang, XiaoFei ^c   Qu, Lei ^a   Cao, ZhongWei ^a   Wang, Bin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Cell invasion; Cell proliferation; GSN; HCC

Indexed keywords

GELATINASE A; GELATINASE B; GELSOLIN; PROTEIN MCL 1;

ADULT; ARTICLE; CARCINOMA CELL; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; TUMOR INVASION; AGED; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FEMALE; GELSOLIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED;

EID: 84940580553     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.06.083     Document Type: Article

References (30)

1. Aravalli R.N., Steer C.J., Cressman E.N. Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008, 48:2047-2063.
2. Asch H.L., Winston J.S., Edge S.B., Stomper P.C., Asch B.B. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion. Breast Cancer Res. Treat. 1999, 55:179-188.
3. Cao Z., Fu B., Deng B., Zeng Y., Wan X., Qu L. Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma. Cancer Cell Int. 2014, 14:86.
4. Chen P., Murphy-Ullrich J.E., Wells A. A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J. Cell Biol. 1996, 134:689-698.
5. Colombo M. Sorafenib in advanced hepatocellular carcinoma: a further step toward personalized therapy of liver cancer. Gastroenterology 2009, 136:1832-1835.
6. De Corte V., Bruyneel E., Boucherie C., Mareel M., Vandekerckhove J., Gettemans J. Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO J. 2002, 21:6781-6790.
7. Dimitroff C.J., Sharma A., Bernacki R.J. Cancer metastasis: a search for therapeutic inhibition. Cancer Investig. 1998, 16:279-290.
8. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
9. Fidler I.J. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother. Pharmacol. 1999, 43(Suppl):S3-S10.
10. Fujita H., Okada F., Hamada J., Hosokawa M., Moriuchi T., Koya R.C., Kuzumaki N. Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect. Int. J. Cancer 2001, 93:773-780.
11. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., McGarry T.J., Kirschner M.W., Koths K., Kwiatkowski D.J., Williams L.T. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997, 278:294-298.
12. Kwiatkowski D.J. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr. Opin. Cell Biol. 1999, 11:103-108.
13. Kwiatkowski D.J. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr. Opin. Cell Biol. 1999, 11:103-108.
14. Kwiatkowski D.J., Stossel T.P., Orkin S.H., Mole J.E., Colten H.R., Yin H.L. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 1986, 323:455-458.
15. Lader A.S., Lee J.J., Cicchetti G., Kwiatkowski D.J. Mechanisms of gelsolin-dependent and -independent EGF-stimulated cell motility in a human lung epithelial cell line. Exp. Cell Res. 2005, 307:153-163.
16. Lee H.K., Driscoll D., Asch H., Asch B., Zhang P.J. Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate. Prostate 1999, 40:14-19.
17. Liang L., Li Q., Huang L.Y., Li D.W., Wang Y.W., Li X.X., Cai S.J. Loss of ARHGDIA expression is associated with poor prognosis in HCC and promotes invasion and metastasis of HCC cells. Int. J. Oncol. 2014, 45:659-666.
18. Pan D., Zeng X., Yu H., Yang Y., Bei C., Bai H., Qiu X. Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection. Gene 2014, 544:32-40.
19. Park Y.M., Cheong H.S., Lee J.K. Genome-wide detection of allelic gene expression in hepatocellular carcinoma cells using a human exome SNP chip. Gene 2014, 551:236-242.
20. Qin J., Luo M., Qian H., Chen W. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1. Gene 2014, 538:342-347.
21. Qu L., Deng B., Zeng Y., Cao Z. Decreased expression of the Nkx2.8 gene correlates with tumor progression and a poor prognosis in HCC cancer. Cancer Cell Int. 2014, 14:28.
22. Roberts L.R. Sorafenib in liver cancer-just the beginning. N. Engl. J. Med. 2008, 359:420-422.
23. Sagawa N., Fujita H., Banno Y., Nozawa Y., Katoh H., Kuzumaki N. Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung cancer cell line, PC10. Br. J. Cancer 2003, 88:606-612.
24. Shieh D.B., Godleski J., Herndon J.N., Azuma T., Mercer H., Sugarbaker D.J., Kwiatkowski D.J. Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression. Cancer 1999, 85:47-57.
25. Sun H.Q., Yamamoto M., Mejillano M., Yin H.L. Gelsolin, a multifunctional actin regulatory protein. J. Biol. Chem. 1999, 274:33179-33182.
26. Tanaka H., Shirkoohi R., Nakagawa K., Qiao H., Fujita H., Okada F., Hamada J., Kuzumaki S., Takimoto M., Kuzumaki N. siRNA gelsolin knockdown induces epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial cells. Int. J. Cancer 2006, 118:1680-1691.
27. Thomas M.B., Zhu A.X. Hepatocellular carcinoma: the need for progress. J. Clin. Oncol. 2005, 23:2892-2899.
28. Thorgeirsson S.S., Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 2002, 31:339-346.
29. Yin H.L., Stossel T.P. Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein. Nature 1979, 281:583-586.
30. Zhu X.C., Dong Q.Z., Zhang X.F., Deng B., Jia H.L., Ye Q.H., Qin L.X., Wu X.Z. microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma. Int. J. Mol. Med. 2012, 30:1321-1326.